Pharma Innovation Aptar CSP Technologies has award-winning Dual Guard active material science technology and a track record of delivering active packaging that extends shelf life and supports drug delivery applications. The company’s pharma focus, including collaborations and recent GLP1 injectable work, signals opportunities to win new contracts for advanced packaging, stability solutions, and regulatory compliant drug delivery components.

Expansion Capacity Recent manufacturing expansion to New Jersey to support clinical-stage packaging for oral solids and capsule-based dry powder inhalers indicates capacity to scale with customers in biotech and pharma. This growth enables on-site prototyping, scale up, and accelerated time to market for new therapies using Activ Polymer and Activ Blister platforms.

Sustainability Focus Launch of the Trigger Spray Pump, a recyclable plastic based dispensing solution for home care, highlights CSP Technologies commitment to sustainable packaging. This strengthens opportunities to offer green packaging options to consumer health, personal care, and pharma customers seeking eco friendly packaging.

GLP1 Opportunity Development efforts around injectable GLP1 solutions and elastomeric components position Aptar CSP as a preferred partner for next generation injectables and combination products, enabling collaborations on primary packaging, containment, and device integration for biotech and pharma customers expanding into injectable therapies.

End to End Advantage As an integrated unit within AptarGroup, CSP Technologies offers end to end services from concept ideation to global production, quality control, and regulatory support. This full service capability is a strong selling point for brands seeking faster development cycles and risk reduction, with potential cross-sell into Aptar’s broader drug delivery and consumer dispensing portfolios.